These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10527800)

  • 1. Experimental models of amyotrophic lateral sclerosis.
    Elliott JL
    Neurobiol Dis; 1999 Oct; 6(5):310-20. PubMed ID: 10527800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The causes and mechanism of selective motor neuron death in amyotrophic lateral sclerosis].
    Van den Bosch L
    Verh K Acad Geneeskd Belg; 2006; 68(4):249-69. PubMed ID: 17214440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Amyotrophic lateral sclerosis and animal models].
    Chritin M; Besson G; Mallaret M; Savasta M
    Rev Neurol (Paris); 2001 Nov; 157(11 Pt 1):1351-61. PubMed ID: 11924004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotrophic factors and amyotrophic lateral sclerosis.
    Ekestern E
    Neurodegener Dis; 2004; 1(2-3):88-100. PubMed ID: 16908980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features that distinguish PLS, upper motor neuron-dominant ALS, and typical ALS.
    Gordon PH; Cheng B; Katz IB; Mitsumoto H; Rowland LP
    Neurology; 2009 Jun; 72(22):1948-52. PubMed ID: 19487653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of caspase-dependent apoptosis in spinal motor neurons of the wobbler mouse.
    Bigini P; Atzori C; Fumagalli E; Cagnotto A; Barbera S; Migheli A; Mennini T
    Neurosci Lett; 2007 Oct; 426(2):106-10. PubMed ID: 17890007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Animal models for motor neuron disease.
    Green SL; Tolwani RJ
    Lab Anim Sci; 1999 Oct; 49(5):480-7. PubMed ID: 10551448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axon guidance proteins: novel therapeutic targets for ALS?
    Schmidt ER; Pasterkamp RJ; van den Berg LH
    Prog Neurobiol; 2009 Aug; 88(4):286-301. PubMed ID: 19523502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of cyclooxygenase-2 protects motor neurons in an organotypic model of amyotrophic lateral sclerosis.
    Drachman DB; Rothstein JD
    Ann Neurol; 2000 Nov; 48(5):792-5. PubMed ID: 11079544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor protects spinal cord motoneurons against glutamate-induced excitotoxicity via phosphatidylinositol 3-kinase.
    Tolosa L; Mir M; Asensio VJ; Olmos G; Lladó J
    J Neurochem; 2008 May; 105(4):1080-90. PubMed ID: 18182045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene-based treatment of motor neuron diseases.
    Federici T; Boulis NM
    Muscle Nerve; 2006 Mar; 33(3):302-23. PubMed ID: 16228969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecal delivery of hepatocyte growth factor from amyotrophic lateral sclerosis onset suppresses disease progression in rat amyotrophic lateral sclerosis model.
    Ishigaki A; Aoki M; Nagai M; Warita H; Kato S; Kato M; Nakamura T; Funakoshi H; Itoyama Y
    J Neuropathol Exp Neurol; 2007 Nov; 66(11):1037-44. PubMed ID: 17984685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal fluid from amyotrophic lateral sclerosis patients preferentially elevates intracellular calcium and toxicity in motor neurons via AMPA/kainate receptor.
    Sen I; Nalini A; Joshi NB; Joshi PG
    J Neurol Sci; 2005 Aug; 235(1-2):45-54. PubMed ID: 15936037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [ALS and neurotrophic factors--HGF as a novel neurotrophic and neuroregenerative factor].
    Funakoshi H; Ohya W; Kadoyama K; Nakamura T
    Brain Nerve; 2007 Oct; 59(10):1195-202. PubMed ID: 17969361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early signs of motoneuron vulnerability in a disease model system: Characterization of transverse slice cultures of spinal cord isolated from embryonic ALS mice.
    Avossa D; Grandolfo M; Mazzarol F; Zatta M; Ballerini L
    Neuroscience; 2006; 138(4):1179-94. PubMed ID: 16442737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyotrophic lateral sclerosis (ALS): a phylogenetic disease of the corticomotoneuron?
    Eisen A; Kim S; Pant B
    Muscle Nerve; 1992 Feb; 15(2):219-24. PubMed ID: 1549143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem cell therapy in amyotrophic lateral sclerosis.
    Meamar R; Nasr-Esfahani MH; Mousavi SA; Basiri K
    J Clin Neurosci; 2013 Dec; 20(12):1659-63. PubMed ID: 24148693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is developmental neuropathology of the motor neurons the key to resolving the mystery in motor neuron diseases?
    Hayashi M
    Brain Dev; 2010 Apr; 32(4):265-7. PubMed ID: 20044225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Introducing Amyotrophic lateral sclerosis.
    Silani V; Meininger V; Fornai F
    Arch Ital Biol; 2011 Mar; 149(1):1-4. PubMed ID: 21412712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.